 |
|
|
| |
Efficacy and Safety of Doravirine in Treatment-Naïve Adults ≥50 Years Old With HIV-1
|
| |
| |
IDWeek 2020 Oct 21-25 virtual
Reported by Jules Levin
Anthony M. Mills1; Elizabeth A. Martin2; Chih-Chin Liu2;Martine Drolet2; Peter Sklar2
1Men's Health Foundation, Los Angeles, CA, USA;2Merck & Co., Inc., Kenilworth, NJ, USA
|
| |
|
|
|
|
|
